T3D Therapeutics Inc
T3D Therapeutics Inc is a biotechnology company based in Durham, North Carolina, focused on developing innovative therapies for Alzheimer's disease through a metabolic approach. Their lead product candidate, T3D-959, aims to address the underlying mechanisms of the disease, aligning with both metabolic and plaque-targeted treatment strategies.
The company boasts a dedicated management team and a scientific advisory board comprised of experts in the field, emphasizing their commitment to advancing research and development in Alzheimer's therapy. T3D Therapeutics is positioned at the forefront of addressing complex neurodegenerative disorders through its unique therapeutic pipeline.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.